SARMs

Payment processing for SARMs operators

SARMs sit in a payment-processing gray zone most operators have mapped the hard way. The compounds are classified as research chemicals, the label claims are tightly watched, and most acquirers keep the vertical off their approval list outright. multiflow doesn't pretend that's changed. What we offer is structure: operators who already have an approved parent account can route SARMs-adjacent sub-brands through a consolidated ledger without every brand being its own processor relationship.

$25k–$600k Typical monthly volume
Research compound DTC Typical brand profile
High Chargeback risk
Specialty-acquirer only Approval outlook
Share this playbook X LinkedIn Reddit HN Email

Why operators in this space find us

What actually brought you here.

  1. 01

    Processor approval is a moving target

    Last month the acquirer said yes. This month they renegotiate "portfolio concentration." Every new brand feels like a fresh underwriting roll. multiflow lets you stop rolling the dice per brand and start routing through one pre-approved parent.

  2. 02

    Research-chemical label claims scrutiny

    Your label says "research use only." Your customer reviews say otherwise. The acquirer knows. multiflow can't change the label or the customer — but we can structure the portfolio so one sub-brand's claims don't blow up the rest.

  3. 03

    Short runway between freezes

    Most operators we onboard have had 3+ processors drop them in 12 months. The runway between setups shrinks every time. Consolidated underwriting at the parent extends the runway because sub-brands don't restart the clock.

  4. 04

    Chargeback rate is structural

    SARMs customers are quick to dispute — sometimes because they read something online, sometimes because the product didn't hit. Either way the chargeback hits the acquirer. Consolidated dispute representment is the only way to keep the ratio inside guidelines at scale.

01

How multiflow works for a SARMs portfolio

multiflow is not an acquirer. We don't issue merchant accounts. What we do is sit on top of an acquirer you're already approved on (Stripe, Square, or Authorize.net under a parent entity) and route sub-brands through that single parent with per-brand descriptors, per-brand Apple Pay, and per-brand refund flow.

For SARMs operators specifically, the structural insulation matters. Running 4 brands on 4 separate merchant accounts means 4 independent underwriting relationships, 4 independent reserve histories, 4 independent freeze risks. multiflow compresses that to one — with the tradeoff being that one freeze blocks the whole portfolio instead of one brand. The math usually favors consolidation once you have 3+ brands.

Underwriting is real. If SARMs is 80% of your catalog and you're not on MATCH, we'll have a conversation about what a defensible parent account looks like. If you're on MATCH, we'll tell you what the path forward requires.

02

What the acquirer actually cares about

In our experience, the acquirer looking at a SARMs-heavy portfolio isn't reading the product page — they're reading the numbers:

  • Chargeback ratio trailing 6 months (Visa VAMP flags at 0.9%, Mastercard ECM at 1%)
  • Refund rate (high refunds = chargeback deflection, which is good; very high refunds = bad product)
  • Dispute representment win rate
  • Reserve + rolling-reserve history
  • Parent entity structure + principal KYC

A SARMs portfolio with clean ratios and a defensible parent entity clears underwriting more often than operators expect. The real blocker is usually the principal's history — if there's a MATCH entry attached, we'll flag it day one.

03

Chargeback representment strategy

SARMs chargebacks tend to cluster around two codes: "product not received" and "product not as described." Both are representable with the right evidence — delivery confirmation for the first, label/description consistency for the second. multiflow aggregates disputes from every sub-brand into one queue so your representment team builds one template library instead of five.

We do not advise on dispute content itself — that's the acquirer's process. What we provide is the context attached (brand, SKU, descriptor, funnel source, affiliate) so your representment packet is 3x faster to assemble.

04

Runway and survival framing

We don't promise your next merchant account lasts forever. We promise structure. With multiflow, the next freeze scopes to the sub-brand that caused it — not the parent and not the siblings. That extends your runway because remediation is isolated, and because operators with consolidated underwriting tend to get more patience from the acquirer than operators opening their 5th separate account.

Operators who've been through 3+ processors typically run out of willing acquirers eventually. We're honest about this with every SARMs applicant. multiflow extends the runway; it doesn't eliminate the risk.

Operators ask us

Quick answers
to the real questions.

01 Will multiflow approve us if we're SARMs-heavy?
Depends on your parent entity, your principal history, your current acquirer, and your trailing volume/chargeback numbers. We'll give you a straight yes/no/conditional inside 48 hours. We say no to roughly 35% of SARMs-heavy applicants, and we're specific about why.
02 What if we're on the MATCH list?
If MATCH is on the principal, you're in structural territory — new principal, new entity, or waiting out the 5-year expiration. If MATCH is on an old entity you've separated from, the new parent may still be approvable.
03 What if our primary acquirer just dropped us?
You're not alone on that. We'll help you evaluate whether your current situation is multiflow-ready (existing approved parent on a sibling processor) or whether you need to reopen the underwriting conversation with a different acquirer first.
04 How do customer statements read?
The brand they bought from, not "multiflow" and not "Acme Holdings LLC." Per-brand soft descriptors are the whole point of the routing layer.
05 Do we keep our current affiliate program?
Yes. Attribution attaches at checkout and flows through the consolidated ledger. Your affiliate platform keeps its existing integration per sub-brand.
06 What's the onboarding timeline?
Day 0: apply. Day 1–2: underwriting decision. Day 3–5: parent wired in, first sub-brand live. Day 6–14: remaining sub-brands fan out in batches. Portfolio-tier operators hit full cutover inside 10 business days typically.
07 Can we mix SARMs with other verticals on the same parent?
Usually yes. Peptides, nutra, nootropics, and SARMs-adjacent supplements can often share a parent account with separate descriptors. The acquirer reviews each descriptor, but the parent underwriting covers the portfolio.
08 What happens if our chargeback ratio spikes?
We notify you before the acquirer does — we watch the ratio at the parent level weekly. If it's climbing toward VAMP territory (0.75%+ trailing), we'll surface which sub-brand is driving it and help you decide whether to pause, change offer structure, or let it ride with heavier representment.

Keep reading

Ready to route
SARMs operators through one parent ledger?

Most operators are approved inside 48 hours. 12 questions, no hard-pull, no obligation.

The Operator Briefing

Twice-monthly. No fluff.

Processor shutdowns, reserve-hold playbooks, reconciliation lessons, and the merchant-account decisions that save operators six-figure years. Delivered to your inbox — never spam.

No spam. Unsubscribe in one click.

We use essential cookies · Privacy